# STRYKER CORP (SYK) FY2024 YTD Q3 P&L / Income Statement

- Company: STRYKER CORP (SYK)
- Period: 2024-01-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-10-30, accession number 0000310764-24-000115
- Page: https://plicit.ai/financials/syk/fy2024-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/syk-fy2024-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Product and Service

Income statement for 2024-01-01 through 2024-09-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 16,159,000,000 US dollars
- **Cost of sales**: 5,893,000,000 US dollars
- **Gross profit**: 10,266,000,000 US dollars
- **Total operating expenses**: 7,158,000,000 US dollars
- **Operating income**: 3,108,000,000 US dollars
- **Other income (expense), net**: negative 144,000,000 US dollars
- **Earnings before income taxes**: 2,964,000,000 US dollars
- **Income taxes**: 517,000,000 US dollars
- **Net earnings**: 2,447,000,000 US dollars
- **MedSurg and Neurotechnology - Endoscopy**: 2,383,000,000 US dollars
- **MedSurg and Neurotechnology - Instruments**: 2,044,000,000 US dollars
- **MedSurg and Neurotechnology - Medical**: 2,710,000,000 US dollars
- **MedSurg and Neurotechnology - Neuro Cranial**: 1,237,000,000 US dollars
- **MedSurg and Neurotechnology - Neurovascular**: 966,000,000 US dollars
- **Orthopaedics and Spine - Hips**: 1,241,000,000 US dollars
- **Orthopaedics and Spine - Knees**: 1,760,000,000 US dollars
- **Orthopaedics and Spine - Other**: 396,000,000 US dollars
- **Orthopaedics and Spine - Spine**: 911,000,000 US dollars
- **Orthopaedics and Spine - Trauma and Extremities**: 2,511,000,000 US dollars
- **Research, development and engineering expenses**: 1,108,000,000 US dollars
- **Selling, general and administrative expenses**: 5,583,000,000 US dollars
- **Amortization of intangible assets**: 467,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/syk/fy2024-ytd-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/syk-fy2024-ytd-q3-revenue-by-geography-sankey.png

Income statement for 2024-01-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 16,159,000,000 US dollars
- **Cost of sales**: 5,893,000,000 US dollars
- **Gross profit**: 10,266,000,000 US dollars
- **Total operating expenses**: 7,158,000,000 US dollars
- **Operating income**: 3,108,000,000 US dollars
- **Other income (expense), net**: negative 144,000,000 US dollars
- **Earnings before income taxes**: 2,964,000,000 US dollars
- **Income taxes**: 517,000,000 US dollars
- **Net earnings**: 2,447,000,000 US dollars
- **UNITED STATES**: 12,070,000,000 US dollars
- **International**: 4,089,000,000 US dollars
- **Research, development and engineering expenses**: 1,108,000,000 US dollars
- **Selling, general and administrative expenses**: 5,583,000,000 US dollars
- **Amortization of intangible assets**: 467,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/syk/fy2024-ytd-q3-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/syk-fy2024-ytd-q3-revenue-by-business-segment-sankey.png

Income statement for 2024-01-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 16,159,000,000 US dollars
- **Cost of sales**: 5,893,000,000 US dollars
- **Gross profit**: 10,266,000,000 US dollars
- **Total operating expenses**: 7,158,000,000 US dollars
- **Operating income**: 3,108,000,000 US dollars
- **Other income (expense), net**: negative 144,000,000 US dollars
- **Earnings before income taxes**: 2,964,000,000 US dollars
- **Income taxes**: 517,000,000 US dollars
- **Net earnings**: 2,447,000,000 US dollars
- **MedSurg and Neurotechnology**: 9,340,000,000 US dollars
- **Orthopaedics and Spine**: 6,819,000,000 US dollars
- **Research, development and engineering expenses**: 1,108,000,000 US dollars
- **Selling, general and administrative expenses**: 5,583,000,000 US dollars
- **Amortization of intangible assets**: 467,000,000 US dollars
- **MedSurg and Neurotechnology costs (calculated)**: 6,751,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Orthopaedics and Spine costs (calculated)**: 4,895,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 1,405,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Geography

- Page: https://plicit.ai/financials/syk/fy2024-ytd-q3-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/syk-fy2024-ytd-q3-revenue-by-business-segment-by-geography-sankey.png

Income statement for 2024-01-01 through 2024-09-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 16,159,000,000 US dollars
- **Cost of sales**: 5,893,000,000 US dollars
- **Gross profit**: 10,266,000,000 US dollars
- **Total operating expenses**: 7,158,000,000 US dollars
- **Operating income**: 3,108,000,000 US dollars
- **Other income (expense), net**: negative 144,000,000 US dollars
- **Earnings before income taxes**: 2,964,000,000 US dollars
- **Income taxes**: 517,000,000 US dollars
- **Net earnings**: 2,447,000,000 US dollars
- **MedSurg and Neurotechnology - UNITED STATES**: 7,232,000,000 US dollars
- **MedSurg and Neurotechnology - International**: 2,108,000,000 US dollars
- **Orthopaedics and Spine - UNITED STATES**: 4,838,000,000 US dollars
- **Orthopaedics and Spine - International**: 1,981,000,000 US dollars
- **Research, development and engineering expenses**: 1,108,000,000 US dollars
- **Selling, general and administrative expenses**: 5,583,000,000 US dollars
- **Amortization of intangible assets**: 467,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.